Medication Comparison

Mounjaro vs Compounded Semaglutide: Which Is Right for You?

A detailed side-by-side comparison of Mounjaro and Compounded Semaglutide, including cost, side effects, dosing, and provider availability.

At a Glance

Mounjaro

FDA Approved
Eli Lilly
tirzepatide
Type 2 Diabetes (off-label for weight loss)
$0/mo from
15Providers

Compounded Semaglutide

Compounded
Various compounding pharmacies
semaglutide
Not FDA-approved as a finished product
$65/mo from
21Providers

Detailed Comparison

FeatureMounjaroCompounded Semaglutide
Active Ingredienttirzepatidesemaglutide
ManufacturerEli LillyVarious compounding pharmacies
FDA ApprovedYesNo
FDA IndicationType 2 Diabetes (off-label for weight loss)Not FDA-approved as a finished product
Dosing ScheduleOnce weeklyOnce weekly
AdministrationSubcutaneous injection (pen)Subcutaneous injection (vial + syringe or pen)
Starting Price (lowest provider)N/A$65/mo
Provider Count1521
Insurance Coverage10 providers5 providers
Weight Loss DataIn the SURMOUNT-1 trial, patients on the highest dose of tirzepatide (15mg) lost an average of 22.5% of body weight over 72 weeks - the highest weight...Since compounded semaglutide uses the same active ingredient, weight loss efficacy should be comparable to brand-name versions when dosed equivalently...

How They Compare

Mounjaro and Compounded Semaglutide represent two distinct approaches to GLP-1 based weight management. Mounjaro contains tirzepatide, a GLP-1 receptor agonist, while Compounded Semaglutide contains semaglutide, a dual GIP/GLP-1 receptor agonist. The dual mechanism of tirzepatide targets two incretin pathways simultaneously, which clinical trials suggest may produce greater average weight loss. However, both medications have proven effective, and the best choice depends on individual factors including insurance coverage, side effect tolerance, and provider availability.

Side Effects Comparison

Mounjaro

Common

  • Nausea (most common during dose escalation)
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion
  • Abdominal pain

Serious (Rare)

  • Pancreatitis
  • Gallbladder problems
  • Hypoglycemia (especially with insulin)
  • Kidney problems
  • Allergic reactions
  • Thyroid C-cell tumors (boxed warning, animal studies)

Compounded Semaglutide

Common

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Decreased appetite
  • Injection site reactions

Serious (Rare)

  • Same serious risks as brand-name semaglutide
  • Pancreatitis
  • Gallbladder problems
  • Kidney injury
  • Thyroid C-cell tumors (theoretical risk)
  • Quality variation between compounding pharmacies

Dosing Schedule Comparison

Mounjaro

Subcutaneous injection (pen) - Once weekly

1
2.5 mg
Initiation - Weeks 1-4
2
5 mg
Escalation 1 - Weeks 5-8
3
7.5 mg
Escalation 2 - Weeks 9-12
4
10 mg
Escalation 3 - Weeks 13-16
5
12.5 mg
Escalation 4 - Weeks 17-20
6
15 mg
Maximum - Week 21+

Compounded Semaglutide

Subcutaneous injection (vial + syringe or pen) - Once weekly

1
0.25 mg
Initiation - Weeks 1-4
2
0.5 mg
Escalation - Weeks 5-8
3
1 mg
Escalation - Weeks 9-12
4
1.7 mg
Escalation - Weeks 13-16
5
2.4 mg
Maintenance - Week 17+

Frequently Asked Questions

What is the difference between Mounjaro and Compounded Semaglutide?

Mounjaro (Tirzepatide) is made by Eli Lilly and is FDA-approved. Compounded Semaglutide (Semaglutide (compounded)) is made by Various compounding pharmacies and is not FDA-approved as a finished product. Mounjaro uses tirzepatide (a GLP-1 agonist) while Compounded Semaglutide uses semaglutide (a dual GIP/GLP-1 agonist), which may produce different weight loss results.

Which is more affordable, Mounjaro or Compounded Semaglutide?

Based on available providers, Mounjaro starts at $0/month while Compounded Semaglutide starts at $65/month. Mounjaro is the more affordable starting option. Actual costs depend on your provider, insurance coverage, and dose level.

Which is more effective for weight loss, Mounjaro or Compounded Semaglutide?

Both medications have shown significant weight loss results. Clinical trials suggest tirzepatide (dual GIP/GLP-1 agonist) may produce slightly greater average weight loss than semaglutide (GLP-1 agonist alone), though individual results vary significantly. Your healthcare provider can help determine which is best for your specific situation.

Can I switch from Mounjaro to Compounded Semaglutide?

Switching between GLP-1 medications is possible but should always be done under medical supervision. Your provider will determine the appropriate starting dose for the new medication and may adjust the transition schedule based on your current dose and response. Since these medications use different active ingredients, your provider may need to restart the dose escalation process.

Find Mounjaro Providers

Compare providers offering Mounjaro near you

Find Providers

Find Compounded Semaglutide Providers

Compare providers offering Compounded Semaglutide near you

Find Providers

Related Comparisons

Medical Disclaimer: This comparison is for educational purposes only and should not replace professional medical advice. Individual results vary. Always consult your healthcare provider before starting or changing any medication.